oral glp-1 Oral GLP-1 Pills for Weight

The additional GIP receptor activity in tirzepatide does not appear to add thyroid risk, as GIP receptors are not significantly expressed on human thyroid C-cells

The orforglipron analysis looks at an oral GLP-1 agonist in development

Some sub-analyses of large clinical trials suggest that GLP-1RA and sodium-glucose cotransporter 2 inhibitor combination therapy may provide more significant reductions in heart failure hospitalization and renal composite events than each alone

But as these injections have spread, the tone has shifted

Navigating the GLP-1 Wave: A Strategic Guide for Plan Sponsors Pain Point : Theres a lack of clear guidance on how to best incorporate and manage coverage for new and expensive GLP-1 medications into existing health plans

This means the drug could be a lot longer acting reducing dosing to potentially just once every two months